Evan is an Investment principal at Philips Ventures based in Amsterdam, and currently serves as a Director of Carevive and Siilo. He’s also a member of the investment council for imec.xpand’s hardware-based nanotechnology fund.
Prior to joining Philips Ventures, Evan was the Chief Business Officer of RareCyte, a venture-backed life science company based in Seattle, Washington. Evan holds an MBA from the University of Oxford — where he was an OUI-SBS Fellow and graduated with distinction — and a bachelor’s degree from Gonzaga University.
You are about to visit a Philips global content page
ContinueThe information on this site is not intended for consumers. The information is directed exclusively to health professionals, health practitioners, persons who are purchasing officers in hospitals, and persons who are engaged in the business of wholesaling therapeutic goods (as per s42AA of the Therapeutic Goods Act 1989 (Cth), and s6 of the Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021).
By clicking “Continue” you are indicating that you are one of the intended audiences. Click cancel to be redirected to the Philips website.